Teijin Pharma Launches WalkAide Device in Japan to Help Stroke Survivors and Others With Partial Paralysis Resume Walking
4/25/2013 10:53:40 AM
More...
|
Teijin Pharma to Launch Ipsen (IPN.PA)'s Somatuline® Subcutaneous Injection in the Treatment of Acromegaly and Pituitary Gigantism in Japan
1/17/2013 9:20:05 AM
More...
|
Teijin Pharma's Febuxostat (FEBURIC) Launches in Taiwan - Novel Drug for Treatment of Hyperuricemia With Gout
5/10/2012 9:05:25 AM
More...
|
Teijin Pharma and Menarini Group Conclude Distribution Agreement for febuxostat in Central and South America, CIS and Oceania
4/11/2012 8:43:32 AM
More...
|
Teijin Pharma's Bonalon Bag for I.V. Infusion 900 µg Approved as Japan's First I.V. Drug for Osteoporosis
1/18/2012 9:04:41 AM
More...
|
NovAliX Enters into Multi-Target Integrated Drug Discovery Collaboration With Teijin Pharma
1/12/2012 9:26:59 AM
More...
|
Astellas Pharma Inc. Obtains China Rights to Teijin Pharma's Gout Treatment
4/2/2010 11:07:51 AM
More...
|
Bristol-Myers Squibb Company (BMY) (JOBS) Enters Global Collaboration with Nissan Chemical Industries, Ltd. and Teijin Pharma on Novel Atrial Fibrillation Compound; Bristol to Pay $40 Million for Heart Drug
3/5/2009 7:46:47 AM
More...
|
Teijin Pharma and Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Announce ULORIC Receives FDA Approval for the Chronic Management of Hyperuricemia in Patients with Gout
2/17/2009 7:59:16 AM
More...
|
Teijin Pharma to Launch Home Healthcare Business in Europe
12/22/2008 8:53:40 AM
More...
|
|